Cargando…
Identification and validation of serum autoantibodies in children with B-cell acute lymphoblastic leukemia by serological proteome analysis
BACKGROUND: B-cell acute lymphoblastic leukemia (B-ALL) is the most common malignancy of childhood. Even though significant progresses have been made in the treatment of B-ALL, some pediatric B-ALL have still poor prognosis. The identification of tumor autoantibodies may have utility in early cancer...
Autores principales: | Yu, Runhong, Yang, Shiwei, Liu, Yufeng, Zhu, Zunmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808998/ https://www.ncbi.nlm.nih.gov/pubmed/35109855 http://dx.doi.org/10.1186/s12953-021-00184-w |
Ejemplares similares
-
iTRAQ-Based Proteomic Analysis Reveals Potential Serum Biomarkers for Pediatric Non-Hodgkin’s Lymphoma
por: Yu, Runhong, et al.
Publicado: (2022) -
Diabetes-Related Autoantibodies in Children With Acute Lymphoblastic Leukemia
por: Bizzarri, Carla, et al.
Publicado: (2012) -
iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia
por: Yu, Runhong, et al.
Publicado: (2019) -
Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities
por: Kourti, Maria, et al.
Publicado: (2023) -
Association of Serum Leptin Level with Obesity in Children with Acute Lymphoblastic Leukemia
por: Zareifar, S, et al.
Publicado: (2015)